Valneva SE (VALN) Change in Cash (2021 - 2026)
Valneva SE (VALN) posted quarterly Change in Cash of -$5.4 million for Q1 2026, up 67.82% year-on-year from -$3.2 million in Q1 2025, and up 86.15% on a QoQ basis from -$38.8 million in Q4 2025.
Valneva SE (VALN) Change in Cash (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Change in Cash for 6 consecutive years, with -$5.4 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash rose 67.82% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.5 million (down 80.08% YoY) and the FY2025 annual result came in at -$62.8 million, down 236.76% from the prior year.
- Change in Cash advanced to -$5.4 million in Q1 2026 per VALN's latest filing, from -$38.8 million in the prior quarter.
- Over the last five years, Change in Cash for VALN reached as high as $92.7 billion in Q3 2023 and fell as low as -$92.8 billion in Q2 2023.
- A 5-year average of -$16.0 million and a median of -$16.7 million in 2025 frame the typical range for Change in Cash.
- The largest YoY upside for Change in Cash was 102973.07% in 2023 against a maximum downside of 338304.55% in 2023.
- Year by year, Change in Cash stood at $35.4 million in 2022, then sank by 245.68% to -$51.5 million in 2023, then soared by 121.25% to $11.0 million in 2024, then tumbled by 454.72% to -$38.8 million in 2025, then jumped by 86.15% to -$5.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$5.4 million, -$38.8 million, and -$20.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.38 Mn |
| Dec 31, 2025 | -38.84 Mn |
| Sep 30, 2025 | -20.26 Mn |
| Jun 30, 2025 | 12.98 Mn |
| Mar 31, 2025 | -16.72 Mn |
| Dec 31, 2024 | 10.95 Mn |
| Sep 30, 2024 | 29.58 Mn |
| Jun 30, 2024 | -52.42 Mn |
| Mar 31, 2024 | 57.84 Mn |
| Dec 31, 2023 | -51.53 Mn |
| Sep 30, 2023 | 92.66 Bn |
| Jun 30, 2023 | -92.75 Bn |
| Mar 31, 2023 | -36.08 Mn |
| Dec 31, 2022 | 35.37 Mn |
| Sep 30, 2022 | -90.07 Mn |
| Jun 30, 2022 | 27.42 Mn |
| Mar 31, 2022 | -40.19 Mn |
| Dec 31, 2021 | 110.46 Mn |
| Sep 30, 2021 | -93.16 Mn |
| Jun 30, 2021 | 106.89 Mn |